Stocks
Seagen Inc.SGEN
NASDAQHealthcareBiotechnology$228.74-0.07%
A biotechnology company focused on developing and commercializing targeted cancer therapies, particularly antibody-drug conjugates that deliver chemotherapy directly to tumor cells. Its portfolio includes approved oncology treatments such as Adcetris, Padcev, Tukysa, and Tivdak, alongside a pipeline...
Market Cap: $43.2B52W Range: $126.47 – $228.96
Congressional Interest in Seagen Inc. (SGEN)
6 members of Congress have disclosed 16 trades in Seagen Inc. (SGEN), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 9 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
16
Unique Politicians
6
Buys
6
Sells
9
Who in Congress Is Trading SGEN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-10-27 | Josh Gottheimer | sell | $1K – $15K |
| 2023-06-26 | Josh Gottheimer | sell | $1K – $15K |